Company news

DiaMedica Therapeutics Inc. news in 2021

DiaMedica Therapeutics Inc.'s news releases, calls and decks from 2021, newest first.

View company

DiaMedica Therapeutics Announces Participation in LifeSci Partners 11th Annual Corporate Access Event

December 12, 2021

DiaMedica Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

November 16, 2021

DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2021 Financial Results

November 9, 2021

DiaMedica Therapeutics to Attend the 12th Annual Craig-Hallum Alpha Select Conference November 16, 2021

November 8, 2021

DiaMedica Therapeutics Announces Addition of Stroke Recurrence as a Second Independent Primary Endpoint in ReMEDy2 Phase 2/3 AIS Trial

November 7, 2021

DiaMedica Therapeutics to Report Third Quarter 2021 Financial Results and Provide a Business Update November 11, 2021

November 3, 2021

DiaMedica Therapeutics Announces Late Breaking Data from REDUX Phase 2 Trial to be Presented at ASN Kidney Week 2021

October 17, 2021

DiaMedica Therapeutics Announces Fast Track Designation Granted to DM199 for the Treatment of Acute Ischemic Stroke

September 29, 2021

DiaMedica Therapeutics Announces $30 Million Private Placement

September 26, 2021

DiaMedica Therapeutics Initiates Pivotal Trial of DM199 for the Treatment of Acute Ischemic Stroke

September 12, 2021

DiaMedica Therapeutics to Participate at Upcoming Investor Conferences

September 6, 2021

DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2021 Financial Results

August 10, 2021

DiaMedica Therapeutics to Report Second Quarter 2021 Financial Results and Provide a Business Update August 12, 2021

August 4, 2021

DiaMedica Therapeutics to Participate in the BTIG Virtual Biotechnology Conference

July 27, 2021

DiaMedica Therapeutics Elects Two Industry Veterans to Its Board of Directors

July 14, 2021

DiaMedica Therapeutics Announces Positive Interim Results from Phase 2 REDUX Study in CKD

June 28, 2021

DiaMedica Therapeutics Announces FDA Clearance of IND Application to Initiate Phase 2/3 Clinical Trial for DM199 for Acute Ischemic Stroke

May 16, 2021

DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2021 Financial Results

May 4, 2021

DiaMedica Therapeutics to Report First Quarter 2021 Financials and Provide a Business Update May 6, 2021

April 27, 2021

DiaMedica Therapeutics Announces 2020 Financial Results and Provides a Business Update

March 9, 2021

DiaMedica Therapeutics to Report Fourth Quarter 2020 Financials and Provide a Business Update March 11, 2021

March 2, 2021

Calls in 2021

Decks in 2021